AbbVie’s Rinvoq shows superiority over Humira in head-to-head arthritis study

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company’s previous bestseller Humira, meeting the main goal of a head-to-head trial.

(Reporting by Puyaan Singh in Bengaluru)